Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra M Arend

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
British Journal of Clinical Pharmacology|December 29, 2025
Use of cimetidine to enhance systemic acyclovir concentrations in patients with ineffective suppressive therapy for recurring herpes simplex virus infections: A novel purpose for an old drugDominique G Stuijt, Victor M Cnossen, Amira F Y S M Osman, et al.
British Journal of Clinical Pharmacology|October 9, 2025
Use of cimetidine to enhance systemic acyclovir concentrations in patients with ineffective suppressive therapy for recurring herpes simplex virus infections: A novel purpose for an old drugDominique G Stuijt, Victor M Cnossen, Amira F Y S M Osman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 11, 2017
Tenosynovitis caused by Mycobacterium malmoense in two kidney transplant recipients and review of the literatureRebecca van Grootveld, Hans U Scherer, Elke E M Peters, et al.
Immunology|November 25, 2003
Human T-cell responses to the RD1-encoded protein TB27.4 (Rv3878) from Mycobacterium tuberculosisElse Marie Agger, Inger Brock, Limei Meng Okkels, et al.
Infection and Immunity|September 14, 2002
Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene familyRikke Louise Vinther Skjøt, Inger Brock, Sandra M Arend, et al.
Clinical and Vaccine Immunology : CVI|May 18, 2007
Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubationEliane M S Leyten, Sandra M Arend, Corine Prins, et al.
Journal of Clinical Microbiology|March 7, 2006
Use of enzyme-linked immunospot assay with Mycobacterium tuberculosis-specific peptides for diagnosis of recent infection with M. tuberculosis after accidental laboratory exposureEliane M S Leyten, Bert Mulder, Corine Prins, et al.
Infection and Immunity|October 24, 2003
PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE familyLimei Meng Okkels, Inger Brock, Frank Follmann, et al.
The Journal of Infectious Diseases|March 19, 2005
ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasiiSandra M Arend, Petra de Haas, Eliane Leyten, et al.
Tuberculosis (Edinburgh, Scotland)|August 14, 2017
Immunological characterization of latent tuberculosis infection in a low endemic countryRoelof A de Paus, Krista E van Meijgaarden, Corine Prins, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|December 29, 2025
Use of cimetidine to enhance systemic acyclovir concentrations in patients with ineffective suppressive therapy for recurring herpes simplex virus infections: A novel purpose for an old drugDominique G Stuijt, Victor M Cnossen, Amira F Y S M Osman, et al.
British Journal of Clinical Pharmacology|October 9, 2025
Use of cimetidine to enhance systemic acyclovir concentrations in patients with ineffective suppressive therapy for recurring herpes simplex virus infections: A novel purpose for an old drugDominique G Stuijt, Victor M Cnossen, Amira F Y S M Osman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 11, 2017
Tenosynovitis caused by Mycobacterium malmoense in two kidney transplant recipients and review of the literatureRebecca van Grootveld, Hans U Scherer, Elke E M Peters, et al.
Immunology|November 25, 2003
Human T-cell responses to the RD1-encoded protein TB27.4 (Rv3878) from Mycobacterium tuberculosisElse Marie Agger, Inger Brock, Limei Meng Okkels, et al.
Infection and Immunity|September 14, 2002
Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene familyRikke Louise Vinther Skjøt, Inger Brock, Sandra M Arend, et al.
Clinical and Vaccine Immunology : CVI|May 18, 2007
Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubationEliane M S Leyten, Sandra M Arend, Corine Prins, et al.
Journal of Clinical Microbiology|March 7, 2006
Use of enzyme-linked immunospot assay with Mycobacterium tuberculosis-specific peptides for diagnosis of recent infection with M. tuberculosis after accidental laboratory exposureEliane M S Leyten, Bert Mulder, Corine Prins, et al.
Infection and Immunity|October 24, 2003
PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE familyLimei Meng Okkels, Inger Brock, Frank Follmann, et al.
The Journal of Infectious Diseases|March 19, 2005
ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasiiSandra M Arend, Petra de Haas, Eliane Leyten, et al.
Tuberculosis (Edinburgh, Scotland)|August 14, 2017
Immunological characterization of latent tuberculosis infection in a low endemic countryRoelof A de Paus, Krista E van Meijgaarden, Corine Prins, et al.
Pageof 5